• Who we are
  • CD28 targeting
  • How it works

Our technology

κλ bodies, truly human

Native, non-engineered, human bispecific antibodies maintain human antibody sequence and structure.

A κλ body consists of:

  • 2 identical heavy chains
  • 2 different light chains: one kappa (κ) and one lambda (λ)

kl bodies truly human 1

 

 

κλ body discovery, a simple process

We first identify antibodies using our common heavy chain antibody libraries. Then, we simply co-express one heavy chain and the two light chains. The bispecific κλ bodies can be directly tested using the cell culture supernatant or easily purified using standard affinity chromatography.

This process ensures a unique level of bsAb purity and integrity

High throughput bsAb screening

Fixed VH Diversified VLs

  • This process ensures a unique level of bsAb purity and integrity

  • High throughput bsAb screening

  • Fixed VH Diversified VLs

New publication in Cancer Immunology Research

NI-3201 Is a Bispecific Antibody Mediating PD-L1–Dependent CD28 Co-stimulation on T Cells for Enhanced Tumor Control

Read more

LinkedIn